TB Diagnostic and IP

Tuberculosis (TB) is a disease of poverty.  TB is a contagious airborne disease that resulted in the deaths of 1.7 million people and 9.4 million new cases in 2009 (WHO 2010).  The vast majority of these victims are in the developing world where most don’t have the financial means or opportunities to receive healthcare.  Since these individuals don’t have the purchasing power or insurance system that the developed world has, treatments for these diseases in the developing world are often neglected by profit driven pharmaceutical companies.  Without a return on investment the major pharmaceutical companies focus their resources on health issues that affect the developed countries….

Read the full Article Here